Implication of tumstatin in tumor progression of human bronchopulmonary carcinomas

Human Pathology

Volumn 35, Issue 10, 2004, Pages 1218-1222

  Caudroy, Stephanie ^a,b   Cucherousset, Joel ^a   Lorenzato, Marianne ^a   Zahm, Jean Marie ^a   Martinella Catusse, Corinne ^a   Polette, Myriam ^a   Birembaut, Philippe ^a  

^a HÔPITAL MAISON BLANCHE   (France)

^b INSERM   (France)

Author keywords

3(IV) chain; v 3 integrin; basement membranes; BM; C terminal noncollagenous domain; matrix metalloproteinase; MMP; NC; tumor angiogenesis; tumstatin

Indexed keywords

ANGIOGENESIS INHIBITOR; BETA3 INTEGRIN; CD51 ANTIGEN; TUMSTATIN; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER GROWTH; CAPILLARY ENDOTHELIUM; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TUMOR VASCULARIZATION;

ADENOCARCINOMA; AUTOANTIGENS; BRONCHI; CARCINOMA, SQUAMOUS CELL; COLLAGEN; COLLAGEN TYPE IV; ENDOTHELIUM, VASCULAR; HUMANS; INTEGRIN ALPHAVBETA3; LUNG NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 5444235720     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.06.008     Document Type: Article

References (26)

1. Butkowski R.J., Langeveld J.P., Wieslander J., et al. Localization of the Goodpasture epitope to a novel chain of basement membrane collagen. J Biol Chem. 262:1987;7874-7877
2. Hostikka S.L., Eddy R.L., Byers M.G., et al. Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome. Proc Natl Acad Sci U S A. 87:1990;1606-1610
3. Kahsai T.Z., Enders G.C., Gunwar S., et al. Seminiferous tubule basement membrane Composition and organization of type IV collagen chains, and the linkage of alpha3(IV) and alpha5(IV) chains. J Biol Chem. 272:1997;17023-17032
4. Kalluri R., Gattone V.H. 2nd, Hudson B.G. Identification and localization of type IV collagen chains in the inner ear cochlea. Connect Tissue Res. 37:1998;143-150
5. Mariyama M., Leinonen A., Mochizuki T., et al. Complete primary structure of the human alpha 3(IV) collagen chain Coexpression of the alpha 3(IV) and alpha 4(IV) collagen chains in human tissues. J Biol Chem. 269:1994;23013-23017
6. Ljubimov A.V., Burgeson R.E., Butkowski R.J., et al. Human corneal basement membrane heterogeneity Topographical differences in the expression of type IV collagen and laminin isoforms. Lab Invest. 72:1995;461-473
7. Polette M., Thiblet J., Ploton D., et al. Distribution of a1(IV) and a3(IV) chains of type IV collagen in lung tumors. J Pathol. 182:1997;185-191
8. Catusse C., Polette M., Coraux C., et al. Modified basement membrane composition during bronchopulmonary tumor progression. J Histochem Cytochem. 48:2000;663-669
9. Maeshima Y., Colorado P.C., Kalluri R. Two RGD-independent alpha v beta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem. 275:2000;23745-23750
10. Han J., Ohno N., Pasco S., et al. Cell binding domain from the alpha3 chain of type IV collagen inhibits proliferation of melanoma cells. J Biol Chem. 272:1997;20395-20401
11. Shahan T.A., Ziaie Z., Pasco S., et al. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells. Cancer Res. 59:1999;4584-4590
12. Pasco S., Han J., Gillery P., et al. A specific sequence of the noncollagenous domain of the alpha3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells. Cancer Res. 60:2000;467-473
13. Floquet N., Pasco S., Ramont L. The anti-tumor properties of the alpha3(IV) 185-203 peptide from the NC1 domain of type IV collagen (Tumstatin) are conformation-dependent. J Biol Chem. 279:2004;2091-2100
14. Martinella-Catusse C., Polette M., Noel A., et al. Down-regulation of MT1-MMP expression by the alpha3 chain of type IV collagen inhibits bronchial tumor cell line invasion. Lab Invest. 81:2001;167-175
15. Maeshima Y., Manfredi M., Reimer C., et al. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J Biol Chem. 276:2001;15240-15248
16. Maeshima Y., Yerramalla U.L., Dhanabal M., et al. Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis. J Biol Chem. 276:2001;31959-31968
17. Hamano Y., Zeisberg M., Sugimoto H., et al. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell. 3:2003;589-601
18. Brambilla E., Travis W.D., Colby T.V., et al. The new World Health Organization classification of lung tumors. Eur Respir J. 18:2001;1059-1068
19. Maeshima Y., Sudhakar A., Lively J.C., et al. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science. 295:2002;140-143
20. O'Reilly M.S., Holmgren L., Shing Y., et al. Angiostatin A circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. Cold Spring Harb Symp Quant Biol. 59:1994;471-482
21. O'Reilly M.S., Boehm T., Shing Y., et al. Endostatin An endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:1997;277-285
22. Yuan A., Yang P.C., Yu C.J., et al. Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer. Am J Respir Crit Care Med. 152:1995;2157-2162
23. Juczewska M., Chyczewska E., Naumnik W., et al. Endothelial cells and angiogenesis intensity in lung cancer. Folia Histochem Cytobiol. 39:2001;253-258
24. Rigau V., Molina T.J., Chaffaud C., et al. Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence. Lung Cancer. 38:2002;169-176
25. Sato H., Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem (Tokyo). 119:1996;209-215
26. Gilles C., Polette M., Piette J., et al. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer. 65:1996;209-213